XML 35 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
GOODWILL AND INTANGIBLE ASSETS
Intangible Assets
The changes in the carrying amount of other intangible assets for the period ending December 31, 2015, were as follows:

 
December 31, 2015
 
December 31, 2014
(Dollars in thousands)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Trademarks and patents
$
2,543

 
$
718

 
$
1,825

 
$
1,046

 
$
364

 
$
682

Technology
47,724

 
19,681

 
28,043

 
33,942

 
15,958

 
17,984

Covenant-not-to-compete
943

 
943

 

 
1,016

 
823

 
193

Customer relationships
49,948

 
9,100

 
40,848

 
19,123

 
4,406

 
14,717

Total definite lived intangible assets
101,158

 
30,442

 
70,716

 
55,127

 
21,551

 
33,576

Indefinite lived intangible assets
4,303

 

 
4,303

 
4,764

 

 
4,764

Total intangible assets
$
105,461

 
$
30,442

 
$
75,019

 
$
59,891

 
$
21,551

 
$
38,340


In the table above, gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.

The indefinite-lived trademark intangible assets were acquired from the acquisition of Curamik. These assets are assessed for impairment annually or when changes in circumstances indicated that the carrying values may be recoverable. The definite-lived intangibles are amortized using a fair value methodology that is based on the projected economic use of the related underlying asset.
On January 22, 2015, we acquired Arlon. For further detail on the goodwill and intangible assets recorded on the acquisition, see Note 5 - Acquisition.
In November 2015, we entered into a technology license agreement with Saber, Inc., which resulted in a $1.0 million intangible asset that will be amortized on a straight-line basis over 5 years.
Amortization expense was approximately $10.9 million, $6.1 million and $6.0 million in 2015, 2014 and 2013, respectively. The estimated annual future amortization expense is $10.6 million, $10.2 million, $9.6 million, $9.1 million and $5.6 million in 2016, 2017, 2018, 2019 and 2020, respectively. These amounts could vary based on changes in foreign currency exchange rates.

The weighted average amortization period as of December 31, 2015, by intangible asset class, is presented in the table below:

Intangible Asset Class
 
Weighted Average Amortization Period
Trademarks and patents
 
3.7
Technology
 
4.1
Customer relationships
 
5.5
Total other intangible assets
 
4.9








Goodwill
The changes in the carrying amount of goodwill for the period ending December 31, 2015, by reportable segment, were as follows:

(Dollars in thousands)
Elastomeric Material Solutions
 
Advanced Connectivity Solutions
 
Power Electronics Solutions
 
Other
 
Total
December 31, 2014
$
23,565

 
$

 
$
72,438

 
$
2,224

 
$
98,227

Arlon acquisition
33,872

 
51,931

 

 

 
85,803

Foreign currency translation adjustment
(1,168
)
 

 
(7,409
)
 

 
(8,577
)
December 31, 2015
$
56,269

 
$
51,931

 
$
65,029

 
$
2,224

 
$
175,453



Annual Impairment Testing

We perform our annual goodwill impairment testing in the fourth quarter of the year. In 2015, we estimated the fair value of our reporting units using an income approach based on the present value of future cash flows. We believe this approach yields the most appropriate evidence of fair value as our reporting units are not easily compared to other corporations involved in similar businesses. We further believe that the assumptions and rates used in our annual impairment test are reasonable, but inherently uncertain. No impairment charges resulted from these analyses.

We currently have four reporting units with goodwill and intangible assets - Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), Curamik and the Elastomer Components Division (ECD). The ACS, EMS, Curamik and ECD reporting units had allocated goodwill of approximately $51.9 million, $56.3 million, $65.0 million and $2.2 million, respectively, at December 31, 2015. No impairment charges resulted from the annual goodwill impairment analysis. The excess of fair value over carrying value for these reporting units was 341.0% for ACS, 208.6% for EMS, 73.8% for Curamik and 232.3% for ECD. These valuations are based on a five year discounted cash flow analysis, which utilized a discount rates ranging from 12.0% for EMS and ECD to 15.3% for Curamik and a terminal year growth rate of 3% for all three reporting units.